India's Sun Pharma In Deal With Italy's Cassiopea To Supply Acne Treatment Winlevi In US, Canada

India's Sun Pharmaceutical Industries Ltd. announced Monday the signing of License and Supply Agreements with Italian specialty pharmaceutical company Cassiopea SpA for acne treatment drug Winlevi (clascoterone cream 1%) in the United States and Canada.

Winlevi is expected to be available in the U.S. in the fourth quarter of calendar 2021.

Winlevi has been approved by the United States Food & Drug Administration or FDA as a novel drug with a unique mechanism of action or MOA for the topical treatment of acne in patients 12 years and older.

Under the deal terms, Sun Pharma will have the exclusive right to commercialize Winlevi in the United States and Canada, and Cassiopea will be the exclusive supplier of the product. Cassiopea will receive an upfront payment of $45 million, potential commercial milestones totaling up to $190 million and customary double digit royalties.

The agreements will close upon the expiration of the HSR waiting period.

The FDA approved Winlevi in August 2020 for the topical treatment of acne vulgaris in patients 12 years and older.Acne, being the most prevalent skin condition in the U.S., affects up to 50 million Americans annually.

The last FDA approval of an acne drug with a new MOA occurred nearly 40 years ago.

Abhay Gandhi, CEO, North America of Sun Pharma, said: "Sun Pharma is pleased to enter into a collaboration with Cassiopea SpA. Winlevi® is a new class of topical medication in dermatology and will complement our existing oral acne portfolio. The addition of Winlevi® further strengthens our position in the acne segment and reinforces our deep commitment to caring and making a difference in the lives of patients."

Diana Harbort, CEO of Cassiopea SpA, "Sun Pharma has a strong established U.S. dermatology presence and will make Winlevi widely available to dermatology health care providers and their patients. Following this transaction, Cassiopea will be expecting substantial revenue streams for the foreseeable future and will be well funded to continue the development of its innovative dermatology pipeline."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter has rolled out the tipping feature called "Tips" for everyone around the globe using the microblogging site with more payment options to choose from, including cryptocurrencies such as Bitcoin. This is a new way for people to receive and show support on Twitter with money. The feature is currently available on iOS and will be available on Android over the coming weeks. Amazon.com has launched weekly Max-Your-Vax Sweepstakes to encourage their employees to get vaccinated against COVID-19. The sweepstakes began on August 6, 2021 and ends on October 21, 2021, with six draws during the sweepstakes period for 18 prizes worth nearly $2 million, including cash prizes, new vehicle or cash and vacation plus 40 hours of Paid Time Off. Target Corp. announced its plans to hire 100,000 seasonal team members at its stores across the country for this holiday shopping season, though fewer than previous years. With this, the company aims to invest in more flexible scheduling, training, pay and benefits for its existing team members. In a statement, the company said it is also offering around 5 million more hours to its existing staff.
Follow RTT